Aurora Cannabis Inc.

NASDAQ:ACB

Drug Manufacturers - Specialty & Generic

Healthcare
$4.40 +0.51%

+$0.02 today

Market cap
$289.28M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $2.73High $6.67

Volume 0.92M

Average 1.00M

ACB Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Aurora Cannabis Inc.NASDAQ: ACB

Gross Margin · Q4 FY2026 · quarter ended Mar 2026

Gross margin widens to 47.7%

Gross margin was 47.7% in Q4 FY2026, up 23.5 pp from a year earlier. On a trailing-twelve-month basis it was 56.6%, up 2.0 pp year over year. Over 3 fiscal years it narrowed by 1.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
47.7%-1.8 pp QoQ
Last fiscal yearMar 2026
5.2%-49.4 pp YoY
LTMMar 2026
56.6%+2.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+23.5 pp——
1 year-49.4 pp——
3 years-1.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2026
5.2%
Year-over-year change
-49.4pp

Gross Margin vs competitors

How ACB compares with its peers on the latest reported figures

  • ACB's LTM Mar 2026 gross margin of 56.6% is the 5th highest of the 11 companies compared; the peer median is 34.5%.
  • Its year-over-year change of +2.0 pp is the 6th highest of 10, against a peer median of +2.9 pp.
  • Over three fiscal years its change of -1.4 pp compares with a peer median of -1.0 pp.
ACB Competitors Peer median
Gross Margin for ACB and competitors
Company Period LTM level YoY 3-year change
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 202699.6% +17.6 pp+0.3 pp
BIOABioAge Labs, Inc.LTM Mar 202699.4% -0.6 pp—
LFMDLifeMD, Inc.LTM Mar 202685.9% -2.1 pp-4.6 pp
ACRSAclaris Therapeutics, Inc.LTM Mar 202676.3% +55.8 pp+13.5 pp
ACBAurora Cannabis Inc.LTM Mar 202656.6% +2.0 pp-1.4 pp
OGIOrganigram Global Inc.LTM Mar 202635.6% +2.9 pp—
TKNOAlpha Teknova, Inc.LTM Mar 202633.3% +12.3 pp-9.0 pp
LFCRLifecore Biomedical, Inc.LTM Mar 202631.2% —-3.8 pp
CGCCanopy Growth CorporationLTM Mar 202624.9% -4.7 pp+39.2 pp
HITIHigh Tide Inc.LTM Apr 202617.5% -8.3 pp-2.4 pp
EDITEditas Medicine, Inc.LTM Mar 20265.8% +124.1 pp+32.1 pp
Peer median (excluding ACB) 34.5%+2.9 pp-1.0 pp

Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M223.8M270.28M343.29M321.42M
Cost of Revenue200.11M209.02M138.82M155.69M304.67M
Gross Profit21.23M14.78M131.46M187.61M16.75M
Gross Margin9.6%6.6%48.6%54.6%5.2%
Research & Development10.39M5.77M3.57M3.68M6.01M
Selling, General & Admin188.99M170.48M156.88M166.47M173.95M
Operating Expenses252.67M221.98M177.91M182.66M179.96M
Depreciation & Amortization93.66M52.59M33.07M22.55M14.23M
EBITDA(1.55B)(135M)(12.34M)51.35M(148.99M)
EBITDA Margin-702.4%-60.3%-4.6%15.0%-46.4%
Operating Income(231.45M)(207.19M)(46.45M)4.95M(163.21M)
Operating Margin-104.6%-92.6%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.86M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(576.51M)(13.15M)15.43M106.54M
Income Before Tax(1.72B)(783.7M)(59.6M)20.38M(56.67M)
Pre-Tax Margin-777.1%-350.2%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)16.55M(554K)4.62M2.1M
Net Income(1.72B)(816.63M)(69.33M)1.59M(122.07M)
Net Margin-776.0%-364.9%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

NASDAQ:ACB

Intrinsic Alpha fair value

Locked

Current Price

$4.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.